Investigative Reporting Landmark Drug Transparency Bill Headed to Full Senate Vote After Crucial Provisions Stripped Away September 20, 2026 Jia Lissa WASHINGTON — A landmark legislative push aimed at pulling back the curtain on the opaque global pharmaceutical manufacturing supply chain is headed for a full Senate vote. However, the measure…
